Peritoneal Malignant Mesothelioma
4 clinical trials · Condition
◉ Watch Peritoneal Malignant Mesothelioma
| Record | Firm | Date |
|---|---|---|
| Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma (NCT05001880) | National Cancer Institute (NCI) | 2022-03-22 |
| Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma (NCT05449366) | Erasmus Medical Center | 2022-02-01 |
| Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma (NCT05193006) | Hospices Civils de Lyon | 2021-12-28 |
| Pembrolizumab in Treating Patients With Malignant Mesothelioma (NCT02399371) | University of Chicago | 2015-03-31 |
Track Peritoneal Malignant Mesothelioma automatically
Every clearance here is in the API, with alerts when new ones post.